HCA:NYSEHCA Healthcare, Inc. analysis

The stock is trading below its 20‑day and 50‑day moving averages, indicating a bearish technical stance. RSI is well under 30, suggesting oversold conditions. The MACD histogram remains negative, reinforcing downward momentum. Despite the price weakness, volume trend is increasing, hinting at possible accumulation. Fundamentals show a modest PE relative to the industry average, yet a negative book value per share raises concerns. Dividend yield sits under 1% with a low payout ratio, pointing to sustainability.
Analyst consensus remains a buy with a median target near $510, implying notable upside. However, a recent max drawdown approaching 28% and 30‑day volatility near 35% highlight heightened risk. The beta is low, indicating limited sensitivity to broader market moves. The fear‑greed index signals extreme greed, which could be inflating the current price. High debt relative to cash balances adds financial leverage risk. Positive free cash flow supports dividend payments and operational flexibility.